cancer clinical trials in richmond, VA
Hunter Holmes McGuire Veteran Affairs Medical Center
Richmond, Virginia 23249 Nosocomial Bacteremia, MRSA Colonization, MRSA Infection, VRE Colonization, VRE Infection
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Endometrial Cancer, Precancerous Condition
|
Virginia Cancer Institute
Richmond, Virginia 23230 Multiple Myeloma
|
MCV Hospital
Richmond, Virginia 23298 Idiopathic Thrombocytopenic Purpura
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Lymphoma
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Leukemia
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Lymphoma
|
Virginia Commonwealth University
Richmond, Virginia Extraocular Retinoblastoma
|
Virginia Commonwealth University
Richmond, Virginia Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Neuroblastoma
|
Veterans Affairs Medical Center - Richmond
Richmond, Virginia 23249 Prostate Cancer
|
Virginia Commonwealth University
Richmond, Virginia Unspecified Adult Solid Tumor, Protocol Specific
|
Viriginia Commonwealth University, Department of Radiation Oncology
Richmond, Virginia 23298 Cervix Cancer
|
Massey Cancer Center/Virginia Commonwealth University
Richmond, Virginia 23298 Melanoma, Soft Tissue Sarcoma, Parathyroid Carcinoma, Small Cell Carcinoma of the Lung, Carcinoid Tumors
|
Massey Cancer Center/Virginia Commonwealth University
Trial Locations Massey Cancer Center/Virginia Commonwealth University Hunter Holmes McGuire Veterans Administration Medical Center Southside Regional Medical Center Prostate Cancer
|
VCU Massey Cancer Center
Richmond, Virginia 23298 Solid Tumor
|
MBCCOP, Virginia Commonwealth University
Trial Locations MBCCOP, Virginia Commonwealth University VCU Massey Cancer Center at Stony Point Breast Cancer
|
Pfizer Investigational Site
Richmond, Virginia 23249 Human Immunodeficiency Virus
|
Virginia Cancer Institute
Richmond, Virginia 23230 Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
|
Pfizer Investigational Site
Richmond, Virginia 23249 Kidney Neoplasms
|
Virginia Commonwealth University
Trial Locations Virginia Commonwealth University Hunter Holmes McGuire Veterans Administration Medical Center Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
Massey Cancer Center/Virginia Commonwealth University
Richmond, Virginia 23298 Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma, Acute Myeloid Leukemia, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
|
Massey Cancer Center / Virginia Commonwealth University
Richmond, Virginia 23298 Myelodysplastic Syndrome
|
Pfizer Investigational Site
Richmond, Virginia 23249 Breast Cancer
|
Virginia Cancer Institute
Richmond, Virginia 23230 Renal Cell Carcinoma
|
Virginia Commonwealth University
Richmond, Virginia Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
Virginia Cancer Institute
Richmond, Virginia 23230 Carcinoma
|
Virginia Commonwealth University
Richmond, Virginia Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
Virginia Commonwealth University
Trial Locations Virginia Commonwealth University Virginia Commonwealth University/MCV Sickle Cell Disease
|
Virginia Commonwealth University
Richmond, Virginia Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|
Virginia Commonwealth University SC
Richmond, Virginia 23284 Leukemia
|
Virginia Commonwealth University Health System
Richmond, Virginia 23298 Type 1 Diabetes Mellitus
|
Virginia Commonwealth University
Richmond, Virginia Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
NMDP Southeast District - Virginia Office
Richmond, Virginia 23229 Healthy
|
Virginia Cancer Institute
Richmond, Virginia 23230 Breast Cancer
|
Virginia Commonwealth University
Richmond, Virginia Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
Virginia Cancer Institute
Richmond, Virginia 23230 Glioblastoma Multiforme
|
Pfizer Investigational Site
Richmond, Virginia 23249 Carcinoma, Non-small Cell
|
Virginia Cancer Institute
Richmond, Virginia 23230 Breast Cancer
|
McGuire DVAMC
Richmond, Virginia 23249 Liver Cancer
|
Virginia Commonwealth University
Richmond, Virginia Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
|
Virginia Cancer Institute
Trial Locations Virginia Cancer Institute Virginia Commonwealth University Metastatic Pancreatic Cancer
|
Virginia Commonwealth University/Massey Cancer Center
Richmond, Virginia 23298 High-grade Salivary Gland Mucoepidermoid Carcinoma, Low-grade Salivary Gland Mucoepidermoid Carcinoma, Recurrent Salivary Gland Cancer, Salivary Gland Acinic Cell Tumor, Salivary Gland Adenocarcinoma, Salivary Gland Adenoid Cystic Carcinoma, Salivary Gland Anaplastic Carcinoma, Salivary Gland Malignant Mixed Cell Type Tumor, Salivary Gland Poorly Differentiated Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
|
Novartis Investigative Site
Richmond, Virginia 23230 Breast Cancer
|
Virginia Commonwealth University, Medical College of Virginia (MCV) Hospital
Richmond, Virginia 23298 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
|
Massey Cancer Center
Richmond, Virginia 23298-0037 Peripheral T-cell Lymphoma
|
Virginia Cancer Institute
Richmond, Virginia 23230 Breast Cancer
|
Virginia Commonwealth University
Richmond, Virginia HIV Infection
|
Virginia Commonwealth University General Clinical Research Center
Richmond, Virginia 23298 Polycystic Ovary Syndrome
|
Veterans Affairs Medical Center - Richmond
Trial Locations Veterans Affairs Medical Center - Richmond Virginia Commonwealth University Massey Cancer Center Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
|
Teva Investigational Site 54
Richmond, Virginia Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma
|
Pfizer Investigational Site
Richmond, Virginia 23249 Breast Cancer
|
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia 23298-0037 Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
|